While there has always been an audience for esports and competitive video games, several trends have come together in the last decade to push this industry over the edge, resulting in an explosion of popularity.
In this segment from Industry Focus: Consumer Goods, Vincent Shen is joined by Motley Fool contributor John Ballard as they field a listener question that leads them to review the history of esports and how faster internet speeds, social media, and major game releases are fueling the growth in this space.
A full transcript follows the video.
This video was recorded on May 22, 2018.
Vincent Shen:
I myself am not a gamer, but I do think esports is only going to get more and more mainstream. I'd like to put together a basket of esports stocks and would be interested to know what you all recommend. It seems there's a few obvious players, but there must be other ancillary companies that are benefiting from the sport's growing popularity.
Best Insurance Stocks To Invest In 2021: Bio-Rad Laboratories, Inc.(BIO.B)
Bio-Rad Laboratories, Inc. (Bio-Rad), incorporated on March 10, 1975, is a manufacturer and distributor of life science research and clinical diagnostics products. The Company manufactures and supplies the life science research, healthcare, analytical chemistry and other markets with a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. Bio-Rad operates in two segments: Life Science and Clinical Diagnostics. The Company's Life Science segment develops, manufactures, sells and services reagents, apparatus and instruments used for biological research. The Company's Clinical Diagnostics segment develops, manufactures, sells and services automated test systems, informatics systems, test kits and specialized quality controls for the healthcare market. Bio-Rad sells over 8,000 products and services to a client base consisting of scientific research, healthcare, education and government customers around the world.
Life Science
The Company's Life Science segment markets and develops, manufactures and markets a range of over 5,000 reagents, apparatus and laboratory instruments that serve a global customer base. Its products are used in established research techniques, biopharmaceutical production processes and food testing regimes. These techniques are used to separate, purify and identify biological materials, such as proteins, nucleic acids and bacteria within a laboratory or production setting. The Company focuses on selected segments of the life sciences market in proteomics (the study of proteins), genomics (the study of genes), biopharmaceutical production, cell biology and food safety. Its life science customers include universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers and food testing laboratories.
Clinical Diagnostics
The Company's Clinical Diagnostic! s segment offers products that serve clinical laboratories in the global diagnostics market. Its products address the in vitro diagnostics (IVD) test market. The Company supplies over 3,000 different products that cover approximately 300 clinical diagnostic tests to the IVD test market. IVD tests are conducted outside the human body and are used to identify and measure substances in a patient's tissue, blood or urine. The Company's products consist of reagents, instruments and software, typically provided to its customers as an integrated package to allow them to generate reproducible test results. Its principal clinical diagnostic customers include hospital laboratories, reference laboratories, transfusion laboratories and physician office laboratories.
The Company competes with GE Biosciences, Merck Millipore, Thermo Fisher Scientific, Roche, Abbott Laboratories, Siemens, Danaher, Becton Dickinson, bioMerieux, Ortho Clinical Diagnostics, Tosoh, Immucor and DiaSorin.
Advisors' Opinion:- [By Joseph Griffin]
Bio-Rad Laboratories (NYSE:BIO.B) and Quanterix (NASDAQ:QTRX) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, risk, dividends, profitability, analyst recommendations, institutional ownership and valuation.
Best Insurance Stocks To Invest In 2021: Golden Nugget Online Gaming, In(GNOG)
Golden Nugget Online Gaming, Inc. operates as an online gaming and digital sports entertainment company. It offers patrons to play their favorite casino games and bet on live-action sports events in New Jersey and Michigan. The company is headquartered in Houston, Texas.
Advisors' Opinion:- [By Dana Blankenhorn]
The latest deal is the all-stock purchase of Golden Nugget Online Gaming (NASDAQ:GNOG), another SPAC I wrote about last December. (Not favorably.) As DraftKings is following online sports betting state-by-state, Golden Nugget is doing the same with online casino gambling.
Best Insurance Stocks To Invest In 2021: CatchMark Timber Trust, Inc.(CTT)
Wells Timberland REIT, Inc., a real estate investment trust (REIT), focuses on the acquisition of timberland properties in the United States. It intends to acquire timberland properties throughout the timber-producing regions of the United States and, to a lesser extent, in timber-producing regions outside the United States. The company intends to qualify as a REIT under the Internal Revenue Code of 1986. Wells Timberland REIT was founded in September 2005. It was formerly known as Wells Real Estate Investment Trust IV, Inc. and changed its name to Wells Timber Real Estate Investment Trust, Inc. in November 2005 and changed to Wells Timberland REIT, Inc. in 2006. The company is headquartered in Norcross, Georgia.
Get a free copy of the Zacks research report on Catchmark Timber Trust (CTT) For more information about research offerings from Zacks Investment Research, visit Zacks.com Catchmark Timber Trust Inc (NYSE:CTT) shares reached a new 52-week low during trading on Tuesday . The stock traded as low as $11.07 and last traded at $11.17, with a volume of 5862 shares trading hands. The stock had previously closed at $11.27. Catchmark Timber Trust Inc (NYSE:CTT) shares hit a new 52-week low during mid-day trading on Thursday . The stock traded as low as $11.67 and last traded at $11.85, with a volume of 1019 shares. The stock had previously closed at $11.72.
No comments:
Post a Comment